Status:
RECRUITING
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
Lead Sponsor:
University of Arkansas
Conditions:
Endocervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distra...
Detailed Description
This will be a prospective pilot study conducted at UAMS. All subjects will experience VR distraction using a crossover design in which each subject receives four rounds of brachytherapy: two rounds w...
Eligibility Criteria
Inclusion
- Female, ≥ 18 years of age
- Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy
- Able to provide written consent
Exclusion
- Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound
- History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras
- Known history of elevated intraocular pressure
- Claustrophobia, thalassophobia, cleithrophobia or similar phobias
- Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen
Key Trial Info
Start Date :
August 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05440760
Start Date
August 8 2022
End Date
December 1 2027
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205